ICON Plc
ICON has conducted hundreds of clinical studies in both solid and haematological tumours, including experience with CAR-T therapies. Vaccines ICON has recently led the development of 17 vaccines resulting in FDA/EMA approvals.
Related contacts of this company（?）
All丨 CEO/Owner/Chairman丨 President/VP/General丨 Purchas/Buy/Import丨 Direct/Manage丨 Engineer/Design
Serial number name Job Title Job Email Operate
View contacts One-click detection Export result One-click marketing